Trinseo Targets Medical Sector with Biocompatible Glass-Filled Polycarbonate

Trinseo Targets Medical Sector with Biocompatible Glass-Filled Polycarbonate

CALIBRE™ 5000 Series supports growth in minimally-invasive surgeries and industry cost reduction

BERWYN, Pa. - Wednesday, October 31, 2018

Trinseo  (NYSE: TSE) a global materials solutions provider and manufacturer of plastics, latex binders and synthetic rubber, is targeting the medical devices market with its biocompatible glass-filled polycarbonate resins. Trinseo’s CALIBRE 5000 series is an ideal material for metal substitution not only because of its strength and stiffness, but its added advantages of aesthetics, ergonomic improvements, and potential cost savings.

“As minimally-invasive surgeries increase and cost pressures continue to mount, Trinseo’s glass-filled polycarbonate is ideal for a variety of surgical tools and surgery access instruments,” said Arthas Yang, global marketing manager in Trinseo’s Performance Plastics business. “The material can be incorporated into a variety of applications, according to design and regulatory requirements, and can help manufacturers with their goals of lowering cost and increasing speed-to-market.”

Glass-filled materials have been used in numerous application areas for years. What differentiates Trinseo’s CALIBRE™ 5000 series is the fact that it has undergone extensive biocompatibility testing according to ISO 10993 standards to provide medical device manufacturers with added assurance of compliancy and patient safety.  

The CALIBRE™ 5000 series offers the following:

  • Custom glass content of up to 30 percent
  • Full battery of ISO 10993 biocompatibility testing
  • UL flammability ratings
  • Sterilizable  by EtO, gamma, and e-beam radiation

From an aesthetic perspective the material can be colored for branding and parts-identification purposes. Due to its processability and the design flexibility it allows, parts can be consolidated for cost savings and simplified assembly, reducing the number of seams and crevasses where bacteria can grow.  

Trinseo has supported the medical devices market for three decades.  The company offers a variety of plastics under the brands CALIBRE™ and CALIBRE™ MEGARAD™ Polycarbonate Resins, EMERGE™ Advanced Resins, MAGNUM™ ABS  Resins, and STYRON™ Polystyrene Resins.  Thermoplastic elastomers offered by Trinseo for soft-touch medical applications are MEGOL™ MED TPS-SEBS Compounds and RAPLAN™ MED TPS-SBS Compounds.

About Trinseo

Trinseo (NYSE: TSE), a specialty material solutions provider, partners with companies to bring ideas to life in an imaginative, smart, and sustainability-focused manner by combining its premier expertise, forward-looking innovations and best-in-class materials to unlock value for companies and consumers.

From design to manufacturing, Trinseo taps into decades of experience in diverse material solutions to address customers’ unique challenges in a wide range of industries, including consumer goods, mobility, building and construction, and medical.

Trinseo’s approximately 3,400 employees bring endless creativity to reimagining the possibilities with clients all over the world from the company’s locations in North America, Europe, and Asia Pacific. Trinseo reported net sales of approximately $4.8 billion in 2021. Discover more by visiting and connecting with Trinseo on LinkedIn, Twitter, Facebook and WeChat.

Cautionary Note on Forward-Looking Statements

This press release may contain forward-looking statements including, without limitation, statements concerning plans, objectives, goals, projections, strategies, future events or performance, and underlying assumptions and other statements, which are not statements of historical facts or guarantees or assurances of future performance. Forward-looking statements may be identified by the use of words like "expect," "anticipate," "intend," "forecast," "outlook," "will," "may," "might," "see," "tend," "assume," "potential," "likely," "target," "plan," "contemplate," "seek," "attempt," "should," "could," "would" or expressions of similar meaning. Forward-looking statements reflect management’s evaluation of information currently available and are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Factors that might cause future results to differ from those expressed by the forward-looking statements include, but are not limited to, our ability to successfully execute our transformation strategy and business strategy; our ability to integrate acquired businesses; global supply chain volatility, increased costs or disruption in the supply of raw materials or increased costs for transportation of our products; the nature of investment opportunities presented to the Company from time to time; and those factors discussed in our Annual Report on Form 10-K, under Part I, Item 1A —"Risk Factors" and elsewhere in our other reports, filings and furnishings made with the U.S. Securities and Exchange Commission from time to time. As a result of these or other factors, our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.